REQUEST A DEMO
Total
USD $0.00
Search more companies

VIOLA GYOGYSZERTAR Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: VIOLA GYOGYSZERTAR Bt. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

VIOLA GYOGYSZERTAR Kereskedelmi es Szolgaltato Bt is a Hungarian company that focuses on virus vector technology, including the Astra-Zeneca COVID-19 Vaccine and the Sputnik V - Gamaleya preparation.

Headquarters
Kossuth Lajos utca 43.
Acs; Komarom-Esztergom; Postal Code: 2941

Contact Details: Purchase the VIOLA GYOGYSZERTAR Bt. report to view the information.

Website: https://violagyogyszertar.hu/

Basic Information
Total Employees:
Purchase the VIOLA GYOGYSZERTAR Bt. report to view the information.
Registered Capital:
Purchase the VIOLA GYOGYSZERTAR Bt. report to view the information.
Financial Auditors:
Purchase the VIOLA GYOGYSZERTAR Bt. report to view the information.
Incorporation Date:
February 15, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
KOMDENT Kereskedelmi es Szolgaltato Kft.
Company Performance
Financial values in the chart are available after VIOLA GYOGYSZERTAR Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
9.72%
Total operating revenue
12.52%
Operating profit (EBIT)
44.12%
EBITDA
44.36%
Net Profit (Loss) for the Period
36.27%
Total Assets
13.47%
Total Equity
11.89%
Operating Profit Margin (ROS)
2.28%
Net Profit Margin
1.77%
Return on Equity (ROE)
4.08%
Quick Ratio
0.26%
Cash Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?